HDCV Comparator — Competitive Intelligence Brief

HDCV Comparator (HDCV Comparator) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated viral vaccine. Area: Immunology / Infectious Disease.

phase 3 Inactivated viral vaccine Rabies virus glycoprotein Immunology / Infectious Disease Biologic

Target snapshot

HDCV Comparator (HDCV Comparator) — Wilbur Chen, MD, MS. HDCV (Human Diploid Cell Vaccine) is a rabies vaccine that stimulates the immune system to produce antibodies against rabies virus.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
HDCV Comparator TARGET	HDCV Comparator	Wilbur Chen, MD, MS	phase 3	Inactivated viral vaccine	Rabies virus glycoprotein
Rabivax-S	Rabivax-S	University of Oxford	marketed	Rabies vaccine	Rabies virus glycoprotein
HyperRAB	HyperRAB	Bio Products Laboratory	marketed	Rabies immunoglobulin (human)	Rabies virus glycoprotein
Rabies immune globulin (human)	Rabies immune globulin (human)	Sanofi Pasteur, a Sanofi Company	marketed	Passive immunizing agent; immunoglobulin	Rabies virus glycoprotein
Rabies vaccines + Rabies immunoglobulins	Rabies vaccines + Rabies immunoglobulins	Novartis	phase 3	Vaccine + Immunoglobulin combination	Rabies virus glycoprotein
Purified Vero Rabies Vaccine	Purified Vero Rabies Vaccine	Sanofi Pasteur, a Sanofi Company	phase 3	Inactivated viral vaccine	Rabies virus glycoprotein
PVRV and pERIG Favirab®	PVRV and pERIG Favirab®	Sanofi Pasteur, a Sanofi Company	phase 3	Monoclonal antibody immunoglobulin (rabies-specific)	Rabies virus glycoprotein

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated viral vaccine class)

1. Sinovac Biotech Co., Ltd · 9 drugs in this class
2. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
3. GlaxoSmithKline · 5 drugs in this class
4. Valneva Austria GmbH · 4 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Centers for Disease Control and Prevention · 3 drugs in this class
7. China National Biotec Group Company Limited · 2 drugs in this class
8. Statens Serum Institut · 2 drugs in this class
9. Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 drugs in this class
10. Crucell Holland BV · 2 drugs in this class